In preclinical studies, reduction in tumor volume along with prolongation of survival were observed in mouse models of prostate cancer treated with the 225Ac-radiolabeled humanized anti-hK2 monoclonal antibody, h11B6, where h11B6 bound only membrane-associated hK2 (8,17). This evidence concerns the gene HK2 and Familial prostate cancer.